STOCK Loxl2tm1.1Acan/Cnbc

Status

Available to order

EMMA IDEM:13005
Citation informationRRID:IMSR_EM:13005 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameSTOCK Loxl2tm1.1Acan/Cnbc
Alternative nameAKB
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolLoxl2tm1.1Acan
Gene/Transgene symbolLoxl2

Information from provider

ProviderAmparo Cano
Provider affiliationBiochemistry, Autonoma University (Medicine Faculty)
Additional ownerFrancisco Portillo and Alberto Martin, Universidad Autónoma de Madrid, Spain.
Genetic informationLoxl2 conditional knock-out.
Phenotypic informationHomozygous:
Normal; no remarkable phenotype.

Heterozygous:
Normal; no remarkable phenotype.
Breeding historyConditional knock-out mutation of Loxl2 based on cre/loxP system was introduced by homologous recombination in the endogenous locus of Loxl2. Positive ES clones for the mutation were microinjected/aggregated into receptive blastocysts/morulas and chimeras were obtained. These animals were crossed with wild-type mice in order to check germline transmision. The resultant heterozygous animals harbouring the conditional knock-out mutation were intercrossed and homozygous animals were obtained.
References
  • Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.;Martin Alberto, Salvador Fernando, Moreno-Bueno Gema, Floristán Alfredo, Ruiz-Herguido Cristina, Cuevas Eva P, Morales Saleta, Santos Vanesa, Csiszar Katalin, Dubus Pierre, Haigh Jody J, Bigas Anna, Portillo Francisco, Cano Amparo, ;2015;The EMBO journal;34;1090-109; 25759215
  • Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.;Salvador Fernando, Martin Alberto, López-Menéndez Celia, Moreno-Bueno Gema, Santos Vanesa, Vázquez-Naharro Alberto, Santamaria Patricia G, Morales Saleta, Dubus Pierre R, Muinelo-Romay Laura, López-López Rafael, Tung Jason C, Weaver Valerie M, Portillo Francisco, Cano Amparo, ;2017;Cancer research;77;5846-5859; 28720577
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivinghomozygous mixed males, homozygous mixed females
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (gene matching)
  • preweaning lethality, incomplete penetrance / IMPC

Literature references

  • Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.;Martin Alberto, Salvador Fernando, Moreno-Bueno Gema, Floristán Alfredo, Ruiz-Herguido Cristina, Cuevas Eva P, Morales Saleta, Santos Vanesa, Csiszar Katalin, Dubus Pierre, Haigh Jody J, Bigas Anna, Portillo Francisco, Cano Amparo, ;2015;The EMBO journal;34;1090-109; 25759215
  • Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.;Salvador Fernando, Martin Alberto, López-Menéndez Celia, Moreno-Bueno Gema, Santos Vanesa, Vázquez-Naharro Alberto, Santamaria Patricia G, Morales Saleta, Dubus Pierre R, Muinelo-Romay Laura, López-López Rafael, Tung Jason C, Weaver Valerie M, Portillo Francisco, Cano Amparo, ;2017;Cancer research;77;5846-5859; 28720577

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).